Saw my doctors and nurses today to conclude my three year phase 3 trial on Exenatide LAR. Took my last shot 1o weeks ago. Morning sugars have gone from an average of 110 during the trial to this mornings 179 high. Within a month I suspect they will be over 200 every morning. A1C came in at 6.4 which shows Exenatide lingers long after the final dose. This is, without a doubt, a great drug and will have a huge impact on how diabetics manage the disease. Naysayers may continue to bash this drug and this company, but to me and other diabetics it will improve our quality of life as well as extend our lives. Thank you Amylin for the opportunity to participate in this trial.